摘要
肺淋巴管平滑肌瘤病是一种罕见的弥漫性肺部疾病。随着对该病研究的不断深入,目前对其发病机制有了更进一步的认识。该病的发生被认为与TSC1或TSC2基因的突变有关,而这可能为该病的治疗提供新的方向。
Pulmonary lymphangioleiomyomatosis (PLAM) is a rare diffuse lung disease. With the progress of the research on PLAM, the pathogenesis of the disease is further understood recently. The occurrence of PLAM is related with the mutation of TSC1 or TSC2 gene, which may provide a basis for new therapeutic strategies.
出处
《国际呼吸杂志》
2009年第16期1011-1014,共4页
International Journal of Respiration
基金
上海市重点学科建设项目资助(B115)
关键词
肺淋巴管平滑肌瘤病
结节性硬化
发病机制
Pulmonary lymphangioleiomyomatosis
Tuberous sclerosis complex
Pathogenesis